All Title Author
Keywords Abstract


Texas and Mexico: Sharing a Legacy of Poverty and Neglected Tropical Diseases

DOI: 10.1371/journal.pntd.0001497

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]  Hotez PJ, Bottazzi ME, Franco-Paredes C, Ault SK, Roses Periago M (2008) The neglected tropical diseases of Latin America and the Caribbean: review of estimated disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis 2: e300. doi:10.1371/journal.pntd.0000300.
[2]  Hotez PJ, Dumonteil E, Heffernan MJ, Bottazzi MD (2012) Innovation for “the bottom 100 million”: eliminating neglected tropical diseases in the Americas through mass drug administration and new vaccines for hookworm and Chagas disease. Adv Exp Med Biol. In press.
[3]  Bottazzi ME, Dumonteil E, Valenzuela J, Betancourt-Cravioto M, Tapia-Conyer R, et al. (2011) Bridging the innovation gap for neglected tropical diseases in Mexico: capacity building for the development of a new generation of antipoverty vaccines. Boletin Medico de Hospital Infantil de Mexico 68: 130.
[4]  Geo-Mexico.com (6 September 2011) Is poverty in Mexico on the rise? Available: http://geo-mexico.com/?p=5075. Accessed 2 March 2012.
[5]  Pan American Health Organization (World Health Organization) (2007) Health in the Americas 2007. Volume I - regional; Volume II - counties. Scientific and technical publication no. 622.
[6]  Por MA, Munoz-Guzman BE, del Rio-Navarro G, Valdivia-Anda F, Alba-Hurtado (2010) The increase in seroprevalence to Toxocara canis in asthmatic children is related to cross-reaction with Ascaris sum antigens. Allergologia et Immunopathologia 38:
[7]  Brentlinger PE, Capps L, Denson M (2003) Hookworm infection and anemia in adult women in rural Chiapas, Mexico. Salud Publica Mex 117–119. doi: 10.1590/S0036-36342003000200008
[8]  Cruz-Reyes A, Pickering-Lopez JM (2006) Chagas disease in Mexico: an analysis of geographical distribution during the past 76 years – a review. Mem Inst Oswaldo Cruz, Rio de Janeiro 101: 345–354. doi: 10.1590/s0074-02762006000400001
[9]  Buekens P, Almendares O, Carlier Y, Dumonteil E, Eberhard M, et al. (2008) Mother-to-child transmission of Chagas disease in North America: why don't we do more? Matern Child Health J 12: 283–286. doi: 10.1007/s10995-007-0246-8
[10]  Pech-May A, Escobedo-Ortegon FJ, Berzunza-Cruz M, Rebollar-Tellez EA (2010) Incrimination of four sandfly species previously unrecognized as vectors of Leishmanias parasites in Mexico. Med Vet Entomol 24: 150–161. doi: 10.1111/j.1365-2915.2010.00870.x
[11]  Rodriguez-Perez MA, Unnasch TR, Dominguez-Vazquez A, Morales-Castro AL, Pena-Flores GP, et al. (2010) Interruption of transmission of Onchocerca volvulus in the Oaxaca focus, Mexico. Am J Trop Med Hyg 83: 21–27. doi: 10.4269/ajtmh.2010.09-0544
[12]  Rodriguez-Perez MA, Unnasch TR, Dominguez-Vazuez A, Morales-Castro AL, Richards F Jr (2010) Lack of active Onchocerca volvulus transmission in the northern Chiapas focus of Mexico. Am J Trop Med Hyg 83: 15–20. doi: 10.4269/ajtmh.2010.09-0626
[13]  Gomez-Dantes H, Willoquet JR (2009) Dengue in the Americas: challenges for prevention and control. Cad. Saude Publica, Rio de Janeiro 25 Sup 1S19–S31.
[14]  Ximenez C, Moran P, Rojas L, Valadez A, Gomez A, et al. (2011) Novelties on amoebiasis: a neglected tropical disease. J Glob Infect Dis 3: 166–174. doi: 10.4103/0974-777X.81695
[15]  Cedillo-Rivera R, Leal YA, Yépez-Mulia L, Gómez-Delgado A, Ortega-Pierres G, et al. (2009) Seroepidemiology of giardiasis in Mexico. Am J Trop Med Hyg 80: 6–10.
[16]  Alvarado-Esquivel C, Torres-Castorena A, Liesenfeld O, García-López CR, Estrada-Martínez S, et al. (2009) Seroepidemiology of Toxoplasma gondii infection in pregnant women in rural Durango, Mexico. J Parasitol 95: 271–274. doi: 10.1645/GE-1829.1
[17]  World Health Organization (n.d.) WHO global health atlas. Available: http://www.who.int/globalatlas. Accessed 2 March 2012.
[18]  World Health Organization (2011) Leprosy update, 2011. Weekly Epidemiol Record 86: 389–400.
[19]  Center for Public Policy Priorities (2010) Poverty 101. Available: http://www.cppp.org/files/8/Pov%20101%20?Sep%2010_Final.pdf. Accessed 2 March 2012.
[20]  Hotez PJ (2008) Neglected infections of poverty in the United States of America. PLoS Negl Trop Dis 2: e256. doi:10.1371/journal.pntd.0000256.
[21]  Upton RG (1936) Incidence and severity of hookworm infestation in East Texas. Am J Public Health Nations Health 26: 924–926. doi: 10.2105/AJPH.26.9.924
[22]  Scott JA (1945) Hookworm disease in Texas. Texas Rep Biol Med 3: 558–568.
[23]  Henderson HE (1957) Incidence and intensity of hookworm infestation in certain East Texas counties with comparison of technics. Texas Rep Biol Med 15: 283–291.
[24]  Shandera WX, White AC Jr, Chen JC, Diaz P, Armstrong R (1994) Neurocysticercosis in Houston, Texas. A report of 112 cases. Medicine (Baltimore) 73: 37–52. doi: 10.1097/00005792-199401000-00004
[25]  White AC Jr, Atmar RI (2002) Infections in Hispanic immigrants. Clin Infect Dis 34: 1627–1632. doi: 10.1086/340620
[26]  Arambulo PV 3rd, Steele JH (1976) Urban dogs in Houston, Texas – parasitic infection and environmental health impact. Int J Zoonoses 3: 114–144.
[27]  Hotez PJ, Wilkins P (2009) Toxocariasis: America's most common neglected infection of poverty and a helminthiasis of global importance? PLoS Negl Trop Dis 3: e400. doi:10.1371/journal.pntd.0000400.
[28]  Hanford EJ, Zhan FB, Lu Y, Giordano A (2007) Chagas disease in Texas: recognizing the significance and implications of evidence in the literature. Soc Sci Med 65: 60–79. doi: 10.1016/j.socscimed.2007.02.041
[29]  Bern C, Montgomery SP (2009) An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 49: e52–e54. doi: 10.1086/605091
[30]  Sarkar S, Strutz SE, Frank DM, Rivaldi C-L, Sissel B, et al. (2010) Chagas disease risk in Texas. PLoS Negl Trop Dis 4: e836. doi:10.1371/journal.pntd.0000836.
[31]  Bern C, Kjos S, Yabsley MJ, Montgomery SP (2011) Trypanosoma cruzi and Chagas' disease in the United States. Clin Microbiol Rev 24: 655–681. doi: 10.1128/CMR.00005-11
[32]  Beard CB, Pye G, Steurer FJ, Rodriguez R, Campman R, et al. (2003) Chagas disease in a domestic transmission cycle in southern Texas, USA. Emerg Infect Dis 9: 103–105. doi: 10.3201/eid0901.020217
[33]  Bowling J, Walter EA (2009) Recognizing and meeting the challenge of Chagas disease in the USA. Expert Rev Anti Infect Ther 7: 1223–1234. doi: 10.1586/eri.09.107
[34]  Enserink M (2000) Infectious diseases. Has leishmaniasis become endemic in the U.S.? Science 290: 1881–1883. doi: 10.1126/science.290.5498.1881
[35]  McHugh CP (2010) Cutaneous leishmaniasis in Texas. J Am Acad Dermatol 62: 508–510. doi: 10.1016/j.jaad.2009.08.034
[36]  Wright NA, David LE, Aftergut KS, Parrish CA, Cockerell CJ (2008) Cutaneous leishmaniasis in Texas: a northern spread of endemic areas. J Am Acad Dermatol 58: 650–652. doi: 10.1016/j.jaad.2007.11.008
[37]  Brunkard JM, Robles Lopez JL, Ramirez J, Cifuentes E, Rothenberg SJ, et al. (2007) Dengue fever seroprevalence and risk factors, Texas-Mexico border, 2004. Emerg Infect Dis 13: 1477–1483. doi: 10.3201/eid1310.061586
[38]  Reiter P, Lathrop S, Bunning M, Biggerstaff B, Singer D, et al. (2003) Texas lifestyle limits transmission of dengue virus. Emerg Infect Dis 9: 86–89. doi: 10.3201/eid0901.020220
[39]  Rico-Hesse R (2007) Dengue virus evolution and virulence models. Clin Infect Dis 44: 1462–1466. doi: 10.1086/517587
[40]  Instituto Carlos Slim de la Salud (2010) Iniciativa Slim para el Desarrollo de Vacunas contra Enfermedades Tropicales. Available: http://www.salud.carlosslim.org/SoluGlob?/Paginas/vacuPage.aspx. Accessed 2 March 2012.
[41]  Limon-Flores AY, Cervera-Cetina R, Tzec-Arjona JL, Ek-Macias L, Sánchez-Burgos G, et al. (2010) Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ cells. Vaccine 28: 7414–7419. doi: 10.1016/j.vaccine.2010.08.104
[42]  Chale-Balboa WG, Mut-Martin M, Ramirez-Sierra MJ, Garcia-Miss MR, Dumonteil E (2009) A combination of DNA vaccine encoding nucleoside hydrolase 36 and glycoprotein 63 protects female but not male hamsters against Leishmania mexicana. Parasite 16: 227–230. doi: 10.1051/parasite/2009163227
[43]  Dumonteil E (2009) Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era. Infect Genet Evol 9: 1075–1082. doi: 10.1016/j.meegid.2009.02.009
[44]  Herrera-Najera C, Pina-Aguilar R, Xacur-Garcia F, Ramirez-Sierra MJ, Dumonteil E (2009) Mining the Leishmania genome for novel antigens and vaccine candidates. Proteomics 9: 1293–1301. doi: 10.1002/pmic.200800533
[45]  Collin N, Gomes R, Teixeira C, Cheng L, et al. (2009) Sand fly proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania. PLoS Pathog 5: e1000441. doi:10.1371/journal.ppat.1000441.
[46]  Gomes R, Teixeira C, Teixera MJ, Oliveira F, Menezes MJ, et al. (2008) Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model. Proc Natl Acad Sci U S A 105: 7845–7850. doi: 10.1073/pnas.0712153105
[47]  Oliveria F, Lawyer PG, Kamhawi S, Valenzuela JG (2008) Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease. PLoS Negl Trop Dis 2: e226. doi:10.1371/journal.pntd.0000226.
[48]  Birmex (n.d.) Birmex website. Available: http://www.birmex.gob.mx. Accessed 2 March 2012.
[49]  Hotez PJ (2008) Training the next generation of global health scientists: a school of appropriate technology for global health. PLoS Negl Trop Dis 2: e279. doi:10.1371/journal.pntd.0000279.
[50]  Hotez P (2010) A national school of tropical medicine and neglected infections of poverty in North America. PLoS Negl Trop Dis 4: e735. doi:10.1371/journal.pntd.0000735.
[51]  Baylor College of Medicine (n.d.) National School of Tropical Medicine website. Available: http://www.bcm.edu/tropicalmedicine. Accessed 2 March 2012.
[52]  Hotez P (27 October 2011) Neglected tropical diseases deserve attention [opinion]. Austin Statesman.
[53]  Hotez PJ, Ferris M (2006) The antipoverty vaccines. Vaccine 24: 5787–5799. doi: 10.1016/j.vaccine.2006.05.008
[54]  Hotez P (2011) A handful of ‘antipoverty’ vaccines exist for neglected diseases, but the world's poorest billion people need more. Health Aff (Millwood) 30: 1080–1087. doi: 10.1377/hlthaff.2011.0317

Full-Text

comments powered by Disqus